Two problems with analyzing natriuretic peptide levels: Obesity and acute myocardial infarction

Korean Circulation Journal

Volumn 40, Issue 11, 2010, Pages 550-551

  Ahn, Min Soo ^a   Yoo, Byung Su ^b  

^a Pusan National University School of Medicine   (South Korea)

^b Yonsei University Wonju College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN NATRIURETIC PEPTIDE; NATRIURETIC FACTOR;

ACUTE HEART INFARCTION; BODY MASS; EDITORIAL; HUMAN; OBESITY;

EID: 78650907942     PISSN: 17385520     EISSN: 17385555     Source Type: Journal    
DOI: 10.4070/kcj.2010.40.11.550     Document Type: Editorial

References (11)

1. Maisel A, Mueller C. North American B-Type Natriuretic Peptide (BNP) Consensus Working Group. Congest Heart Fail 2008;14(4 Suppl 1):4.
2. Bettencourt P, Januzzi JL Jr. Amino-terminal pro-B-type natriuretic peptide testing for inpatient monitoring and treatment guidance of acute destabilized heart failure. Am J Cardiol 2008;101:67-71.
3. Eggers KM, Lagerqvist B, Venge P, Wallentin C, Lindahl B. Prognostic value of biomarkers during and after non-ST-segment elevation acute coronary syndrome. J Am Coll Cardiol 2009;54:357-64.
4. Bayes-Genis A, DeFilippi C, Januzzi JL Jr. Understanding amino-terminal pro-B-type natriuretic peptide in obesity. Am J Cardiol 2008;101: 89-94.
5. Horio T, Shimada K, Kohno M, et al. Serial changes in atrial and brain natriuretic peptides in patients with acute myocardial infarction treated with early coronary angioplasty. Am Heart J 1993;126:293-9.
6. Choi SG, Jeong MH, Ahn Y, et al. Relationship between obesity and N-terminal brain natriuretic peptide level as a prognostic value after acute myocardial infarction. Korean Circ J 2010;40:558-64.
7. Shah K, Terracciano GJ, Jiang K, Maisel AS, Fitzgerald RL. Comparability of results between point-of-care and automated instruments to measure B-type natriuretic peptide. West J Emerg Med 2010;11:44-8.
8. Horwich TB, Hamilton MA, Fonarow GC. B-type natriuretic peptide levels in obese patients with advanced heart failure. J Am Coll Cardiol 2006;47:85-90.
9. Tapanainen JM, Lindgren KS, Makikallio TH, Vuolteenaho O, Leppaluoto J, Huikuri HV. Natriuretic peptides as predictors of non-sudden and sudden cardiac death after acute myocardial infarction in the beta-blocking era. J Am Coll Cardiol 2004;43:757-63.
10. Maisel A, Mueller C, Adams K Jr, et al. State of the art: using natriuretic peptide levels in clinical practice. Eur J Heart Fail 2008;10: 824-39.
11. Choe HM, Yoo BS, Ryu HY, et al. The early changing pattern of the B-Type natriuretic peptide concentration and its significance as a prognostic marker after acute myocardial infarction. Korean Circ J 2006; 36:526-34.